All compounds described on this website are supplied strictly for in-vitro laboratory research. They are not for human or veterinary use, and no medical or therapeutic claims are made.
Research category
GHRH analogues and growth-hormone secretagogues used to study pituitary signalling and the GH/IGF-1 axis.
Every compound below is supplied at 99% purity (HPLC) for in-vitro laboratory research. Open a profile for technical data, research background and references, or enquire to order directly.
Growth Hormone Axis Research99% purityTetrasubstituted GHRH(1-29) analogue
A 29-amino-acid GHRH analogue with four substitutions that improve stability. The 'no DAC' form lacks the drug-affinity-complex maleimide linker present in the long-acting CJC-1295 studied clinically.
Growth Hormone Axis Research99% puritySynthetic hexapeptide growth-hormone secretagogue
A second-generation GHRP with higher potency than GHRP-6. Approved in Japan as a diagnostic agent (pralmorelin) for growth-hormone deficiency.
Growth Hormone Axis Research99% puritySynthetic hexapeptide growth-hormone secretagogue
One of the first synthetic growth-hormone-releasing peptides, developed from met-enkephalin analogues. Its discovery led to the identification of the ghrelin receptor.
Growth Hormone Axis Research99% puritySynthetic hexapeptide growth-hormone secretagogue
A GHRP-6 analogue with a 2-methyl-tryptophan substitution, studied for GH release and, separately, for cardiac effects attributed to CD36 binding.
Growth Hormone Axis Research99% purityPentapeptide growth-hormone secretagogue (ghrelin receptor agonist)
A synthetic pentapeptide agonist of the growth-hormone secretagogue receptor (GHS-R1a). Described in its original publication as selective for GH release with little effect on ACTH or cortisol.
Growth Hormone Axis Research99% puritySynthetic GHRH(1-29) amide
The N-terminal 29-amino-acid fragment of human GHRH, which retains full receptor activity. Formerly marketed as a diagnostic and therapeutic agent; now used in research as a reference GHRH agonist.
Growth Hormone Axis Research99% puritySynthetic GHRH(1-44) analogue (trans-3-hexenoyl modified)
A stabilised analogue of growth-hormone-releasing hormone (GHRH). Licensed in some jurisdictions for a specific indication; used in research to study the hypothalamic–pituitary GH axis.
For laboratory research only. All compounds described on this website are supplied strictly for in-vitro laboratory research. They are not for human or veterinary use, and no medical or therapeutic claims are made. Researchers remain responsible for complying with the rules that apply to them.
Full disclaimer